Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Diabetes and Prediabetes, and Achievements in Diabetes Control in Iran; the Results of the Steps of 2016 Publisher Pubmed



Shahraz S1 ; Saeedi Moghaddam S2 ; Azmin M2 ; Peykari N2, 3 ; Yoosefi M2 ; Mohebi F2, 4 ; Khatibzadeh S5 ; Fateh SM2, 6 ; Djalalinia S2, 7 ; Modirian M2 ; Mahmoudi N2 ; Mahmoudi Z2 ; Dashti S2 ; Hezaveh AM8 Show All Authors
Authors
  1. Shahraz S1
  2. Saeedi Moghaddam S2
  3. Azmin M2
  4. Peykari N2, 3
  5. Yoosefi M2
  6. Mohebi F2, 4
  7. Khatibzadeh S5
  8. Fateh SM2, 6
  9. Djalalinia S2, 7
  10. Modirian M2
  11. Mahmoudi N2
  12. Mahmoudi Z2
  13. Dashti S2
  14. Hezaveh AM8
  15. Larijani B6
  16. Farzadfar F2, 6
Show Affiliations
Authors Affiliations
  1. 1. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, United States
  2. 2. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Deputy for Education, Ministry of Health and Medical Education, Tehran, Iran
  4. 4. Haas School of Business, University of California, Berkeley, 94720, CA, United States
  5. 5. Brandeis University, Heller School for Social Policy and Management, Waltham, MA, United States
  6. 6. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran
  8. 8. Center for Noncommunicable Disease Control and Prevention, Ministry of Health and Medical Education, Tehran, Iran

Source: Archives of Iranian Medicine Published:2022


Abstract

Background: Using the WHO STEPwise approach to NCD risk factor surveillance (STEPS), first round of Iran’s STEPS completed in 2005. It has been repeated six times afterward. Here we report the results of 2016 round on the population characteristics and prevalence of diabetes and prediabetes, along with an assessment of the country-level performance on diabetes care in Iran. Methods: Using a proportional-to-size cluster random sampling method, the STEPS 2016 included 18 947 subjects aged ≥ 25 years who matched the criteria (non-missing information on diabetes self-report, and biomarkers). For the analyses, survey design methods with weighted samples were employed. Different definitions of diabetes (biomarker-based, self-report, anti-diabetes medication use, or a combination) and prediabetes (different cutpoints of the biomarker) were calculated and presented. Results: An estimated 5 171 035 persons aged ≥ 25 years or 10.6% (95% CI: 10.0%–11.1%) had diabetes according to the serologic diagnosis of diabetes (FPG ≥ 126 mg/dL) or the use of at least one anti-diabetes medication (1896 out of 18 947). Employing the serologic diagnosis of diabetes among those who responded no to the self-reported question, 2.7% (2.5%–3.0%) of the population were not aware of their diabetes compared to 11.5% (10.9%-12.0%) who were diabetics according to the just self-reported question. Defining prediabetes as 100 ≤ FPG < 126 mg/dL or 5.7 ≤ HbA1c < 6.5%, an estimated 15 244 299 persons had prediabetes (5885 out of 18 947). Overall, 52.1% (49.4%–54.7%) of patients with self-reported diabetes were under strict glycemic control (HbA1c < 7%). Poor diabetes control (HbA1c > 9%) was found in 18.4% (16.3%-20.6%) of the patients with self-reported diabetes. Conclusion: Since 2005, the prevalence of diabetes in Iran has been on a gradual increase in both genders with an increasing gap between females and males. © 2022 Academy of Medical Sciences of I.R. Iran. All rights reserved.
Other Related Docs
27. Iran in Transition, The Lancet (2019)
35. Diabetes Mellitus and Its Risk Factors Among a Middle-Aged Population of Iran, a Population-Based Study, International Journal of Diabetes in Developing Countries (2016)
38. Trend of Years of Life Lost Due to Suicide in Iran (2006–2015), International Journal of Public Health (2018)
42. A New Model for Optimization of Diabetes Clinics With the Case Study in Iran, Journal of Diabetes and Metabolic Disorders (2022)